3.1. epidemiology. bladder cancer 7th commonly diagnosed cancer males, whilst drops 10th position genders considered . worldwide age-standardised incidence rate (per 100,000 person/years) 9.5 men 2.4 women . european union, age-standardised incidence rate 20 men 4.6 women . europe, highest age-standardised incidence rate reported belgium (31 men 6.2 women) lowest finland (18.1 men 4.3 women) . worldwide, bc age-standardised mortality rate (per 100,000 person/years) 3.3 men vs. 0.86 women 2012 . bladder cancer incidence mortality rates vary across countries due differences risk factors, detection diagnostic practices, availability treatments. variations are, however, also partly caused different methodologies used studies quality data collection . incidence mortality bc decreased registries, possibly reflecting decreased impact causative agents . approximately 75% patients bc present disease confined mucosa (stage ta, carcinoma situ [cis]) submucosa (stage t1). younger patients (< 40 years) percentage even higher . patients tat1 cis high prevalence due long-term survival many cases lower risk cancer-specific mortality (csm) compared t2-4 tumours .